or
Bookmark and Share
Composition for treatment of infections of humans and animals
   
Document Number
US Patent 6649660
Issued Date
November 18, 2003
Link
Inventors
Ninkov; Dusan (Orange City, IA)
Map
Abstract
This disclosure provides pharmaceutical compositions which include oil extract from plants from the Labiatae family. In particular, the compositions can be formulated by combining extracts of essential oils from plants of the Labiatae family with an organic acid or a Group I salt. It is believed that the antimicrobial activity of the pharmaceutical composition is due to the presence of organic phenols, such as isopropyl-o-cresol, in the oil extract from the plants.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
18
Comments:
no comments yet
Owner
Published
November 18, 2003
Application Number
10/143,096
Filed
May 10, 2002
US Classification
514/731  
Int'l Classification
B01F   7/16   (20060101)   B01F   7/22   (20060101)   A61K   31/045   (20060101)   A61K   31/05   (20060101)   B01F   15/06   (20060101)   B01F   15/00   (20060101)  
Attorney/Law Firm
Parent Case
This application is a continuation of application Ser. No. 09/499,197, filed Feb. 7, 2000, now U.S. Pat. No. 6,414,036. Application Ser. No. 09/499,197, claims priority to Provisional Application Ser. No. 60/151,858, filed Sep. 1, 1999, which applications are incorporated herein by reference.
USPTO Field of Search
514/731  
Related Patents
7411005 - Compositions and methods for increasing milk production in animals - Owned by Van Beek Natural Science, LLC (Orange City, IA)

The invention provides A composition for increasing milk production in an animal that includes an active compound chosen from calcium isopropyl cresol, calcium isopropyl-o-cresol, lactic acid, or combinations thereof, and calcium carbonate as a buffering agent. The invention also provides a composition for increasing milk production in an animal that includes about 0.1 wt % to about 15 wt % of the total weight of the composition of active compound, wherein the active compound is chosen from calcium isopropyl cresol, calcium isopropyl-o-cresol, and lactic acid, about 40 wt % to about 75 wt % of the total weight of the composition of calcium carbonate, and about 10 wt % to about 60 wt % of the total weight of the composition of at least one carrier. The invention also provides a method for increasing milk production in an animal that includes making a composition having an active compound chosen from calcium isopropyl cresol, calcium isopropyl-o-cresol, lactic acid, or combinations thereof, and calcium carbonate as a buffering agent, and feeding the composition to the animal, wherein consumption of the composition increases milk production in the animal.

7517541 - Oral care compositions derived from the Labiatae family - Owned by A.M. Todd Company (Montgomeryville, PA)

The invention relates to water dispersible extract preparations derived from water soluble components of Labiatae family plant material, including plant material hay and previously extracted or spent hay, which possesses beneficial oral care properties, methods of their manufacturing and application of the preparations in oral care products.

7465697 - Essential oils based cleaning and disinfecting compositions - Owned by Ohsoclean, Inc. (San Francisco, CA)

The present invention provides cleaning and disinfecting compositions for cleaning, disinfecting and sanitizing inanimate and animate surfaces. The cleaning and disinfecting compositions contain thyme oil or thyme oil and origanum oil, a salt of a transition metal, sodium dioctyl sulfosuccinate and water. The cleaning and disinfecting compositions of the present invention are surprisingly stable and as such, they may be provided to consumers in the undiluted state. The cleaning and disinfecting compositions of the present invention are botanical, environmentally sustainable, non-toxic and mildly scented.

7135191 - Urogenital or anorectal transmucosal vaccine delivery system

The invention is directed to a suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals and a method for treating the same. More particularly, this invention is directed to a suppository based vaccine delivery system for the prophylaxis against or treatment of urogenital or anorectal transmitted infectious diseases, such as from viral or microbial pathogens. The suppository based delivery system comprises vaccine and/or vaccine adjuvant(s) comprised of whole or fractionated viral or other microbial pathogens, or their purified cellular constituents, whether native, mutated, synthetic, cloned or recombinantly expressed, that consists of nucleic acids, proteins, lipids or other antigenic determinants capable of producing humoral or cellular-mediated immunity in humans or animals; and a polyethylene glycol base; wherein the suppository is adapted to be inserted into a bodily orifice of a human or animal so as to allow the suppository to be in contact with tissue of the bodily orifice to facilitate transfer of vaccine or vaccine adjuvant(s) material therethrough.

7541155 - Methods of screening compositions for potential insect control activity - Owned by Tyratech, Inc. (Melbourne, FL)

The present invention comprises compositions, methods and cell lines related to controlling insects. An embodiment of a composition comprises a plant essential oil and targets at least one receptor of insects chosen from tyramine receptor, Or83b olfactory receptor, and Or43a olfactory receptor, resulting in a change in the intracellular levels of cAMP, Ca2+, or both in the insects.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us